Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study.

about

Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study.

Item

http://www.wikidata.org/entity/Q47744428

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Amisulpride in the prevention ...... rapy: a dose-escalation study.

@en

Amisulpride in the prevention ...... rapy: a dose-escalation study.

@nl

type

Item

label

Amisulpride in the prevention ...... rapy: a dose-escalation study.

@en

Amisulpride in the prevention ...... rapy: a dose-escalation study.

@nl

prefLabel

Amisulpride in the prevention ...... rapy: a dose-escalation study.

@en

Amisulpride in the prevention ...... rapy: a dose-escalation study.

@nl

P1476

Amisulpride in the prevention ...... erapy: a dose-escalation study

@en

P2093

Gabriel M Fox

http://www.w3.org/2001/XMLSchema#string

Jørn Herrstedt

http://www.w3.org/2001/XMLSchema#string

Karin Holmskov

http://www.w3.org/2001/XMLSchema#string

Paul D Taylor

http://www.w3.org/2001/XMLSchema#string

Thomas B Christensen

http://www.w3.org/2001/XMLSchema#string

Yvonne Summers

http://www.w3.org/2001/XMLSchema#string

P2860

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial

Safety of amisulpride (Solian): a review of 11 clinical studies

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.

Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.

Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?

Metabolic drug interactions with newer antipsychotics: a comparative review.

Chlorpromazine, placebo and droperidol in the treatment of nausea and vomiting associated with cisplatin therapy

Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects.

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

P2888

s00520-017-3825-2

P304

139-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-017-3825-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gedske Daugaard

Alex Molassiotis

P577

2017-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28801850

http://www.w3.org/2001/XMLSchema#string